Dermatology, MOHS-Micrographic Surgery · Randolph, NJ
NPI
1760694038
Since 2007
Specialty
Dermatology, MOHS-Micrographic Surgery
Code 207ND0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
390 Route 10 West
Randolph, NJ, 07869
Phone (973) 366-6303
Groups this clinician bills Medicare through
Medicare paid, 2024
$286K
2,700 services
Medicare patients, 2024
692
Average age 76
Drug cost, 2024
$4.5M
1,377 prescriptions
Company payments, 2025
$1,238
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Najarian was code 17003 (destruction skin lesion), 412 times for 78 patients. In total David J Najarian billed 2,700 services in 60 codes, and Medicare paid $286K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 412 | 78 | $5.74 | $2,365 |
| 99214 Office E&M - Established | Office | 344 | 226 | $105.92 | $36K |
| 99213 Office E&M - Established | Office | 336 | 260 | $76.56 | $26K |
| 99215 Office E&M - Established | Office | 248 | 143 | $151.35 | $38K |
| 99212 Office E&M - Established | Office | 220 | 173 | $48.27 | $11K |
| 17000 Destruction Skin Lesion | Office | 146 | 119 | $49.90 | $7,285 |
| 11102 Skin Biopsy | Office | 131 | 119 | $83.92 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 120 | 84 | $14.78 | $1,773 |
| 17311 Mohs Surgery | Office | 92 | 80 | $615.43 | $57K |
| 99203 Office E&M - New | Office | 80 | 80 | $77.34 | $6,187 |
| 99204 Office E&M - New | Office | 76 | 76 | $135.92 | $10K |
| 17110 Destruction Skin Lesion | Office | 63 | 59 | $100.31 | $6,320 |
| 11103 Skin Biopsy | Office | 54 | 34 | $44.73 | $2,415 |
| 99205 Office E&M - New | Office | 37 | 37 | $199.56 | $7,384 |
| 12032 Wound Repair - All Levels | Office | 35 | 34 | $249.96 | $8,749 |
By year: 2022 $237K for 2,535 services; 2023 $250K for 2,614 services; 2024 $286K for 2,700 services.
Medicare prescription drug claims, 2024
In 2024, the drug David J Najarian prescribed most often to Medicare patients was Triamcinolone Acetonide, with 193 prescriptions and refills. In total David J Najarian wrote 1,377 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 193 | 257 | 118 | $2,084 |
| Humira(Cf) Pen Adalimumab | 101 | 105 | 14 | $1.1M |
| Cosentyx Unoready Pen Secukinumab | 91 | 97 | 21 | $1.3M |
| Dupixent Pen Dupilumab | 88 | 97 | 12 | $370K |
| Clobetasol Propionate Generic | 83 | 134 | 41 | $5,908 |
| Otezla Apremilast | 83 | 87 | 13 | $413K |
| Fluocinonide Generic | 81 | 112 | 57 | $3,787 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 78 | 78 | 11 | $624K |
| Ketoconazole Generic | 63 | 74 | 32 | $1,650 |
| Mounjaro Tirzepatide | 61 | 61 | Under 11 | $60K |
| Cephalexin Generic | 35 | 37 | 28 | $180 |
| Doxycycline Hyclate Generic | 34 | 57 | 20 | $2,083 |
| Tacrolimus Generic | 23 | 34 | 15 | $1,491 |
| Rybelsus Semaglutide | 21 | 22 | Under 11 | $22K |
| Mupirocin Generic | 18 | 18 | 14 | $110 |
Brand drugs: - claims; generic drugs: 737 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Najarian $1,238 ($1,238 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $307.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 30 | $307 |
| Janssen Biotech, Inc. JNJ | 9 | $254 |
| UCB, Inc. UCB.BR | 15 | $149 |
| LEO Pharma Inc. | 11 | $147 |
| Lilly USA, LLC LLY | 4 | $83.75 |
| Pfizer Inc. PFE | 5 | $81.47 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $37.71 |
| Amgen Inc. AMGN | 2 | $35.7 |
| Genzyme Corporation SNY | 2 | $32.7 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $25.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.